(Q42420172)

English

Mortality associated with administration of high-dose tranexamic acid and aprotinin in primary open-heart procedures: a retrospective analysis

scientific article published on 3 August 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

30 October 2017

Mortality associated with administration of high-dose tranexamic acid and aprotinin in primary open-heart procedures: a retrospective analysis (English)

1 reference

Europe PubMed Central

PMC publication ID

30 October 2017

tranexamic acid

1 reference

based on heuristic

inferred from title

Christian von Heymann

6

object named as

Christian von Heymann

1 reference

Europe PubMed Central

PMC publication ID

30 October 2017

Klaus-Dieter Wernecke

5

object named as

Klaus-Dieter Wernecke

1 reference

Europe PubMed Central

PMC publication ID

30 October 2017

2

object named as

Claudia D Spies

1 reference

Europe PubMed Central

PMC publication ID

30 October 2017

author name string

Michael Sander

1

1 reference

Europe PubMed Central

PMC publication ID

30 October 2017

Viktoria Martiny

3

1 reference

Europe PubMed Central

PMC publication ID

30 October 2017

Christoph Rosenthal

4

1 reference

Europe PubMed Central

PMC publication ID

30 October 2017

publication date

3 August 2010

1 reference

Europe PubMed Central

PMC publication ID

30 October 2017

1 reference

Europe PubMed Central

PMC publication ID

30 October 2017

14

1 reference

Europe PubMed Central

PMC publication ID

30 October 2017

4

1 reference

Europe PubMed Central

PMC publication ID

30 October 2017

R148

1 reference

Europe PubMed Central

PMC publication ID

30 October 2017

https://scigraph.springernature.com/pub.10.1186/cc9216

0 references

High-dose tranexamic Acid is associated with nonischemic clinical seizures in cardiac surgical patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945131

28 May 2018

The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2--isolated valve surgery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945131

28 May 2018

Aprotinin: 1 year on.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945131

28 May 2018

The blood sparing effect and the safety of aprotinin compared to tranexamic acid in paediatric cardiac surgery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945131

28 May 2018

A comparison of aprotinin and lysine analogues in high-risk cardiac surgery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945131

28 May 2018

The effect of aprotinin on outcome after coronary-artery bypass grafting

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945131

28 May 2018

Aprotinin during coronary-artery bypass grafting and risk of death

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945131

28 May 2018

Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945131

28 May 2018

Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945131

28 May 2018

The risk associated with aprotinin in cardiac surgery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945131

28 May 2018

Are antifibrinolytic drugs equivalent in reducing blood loss and transfusion in cardiac surgery? A meta-analysis of randomized head-to-head trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945131

28 May 2018

Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945131

28 May 2018

Tranexamic acid, a widely used antifibrinolytic agent, causes convulsions by a gamma-aminobutyric acid(A) receptor antagonistic effect

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945131

28 May 2018

Convulsive seizures following subdural application of fibrin sealant containing tranexamic acid in a rat model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945131

28 May 2018

Cerebral injury after cardiac surgery: identification of a group at extraordinary risk. Multicenter Study of Perioperative Ischemia Research Group (McSPI) and the Ischemia Research Education Foundation (IREF) Investigators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945131

28 May 2018

Aprotinin in primary valve replacement and reconstruction: a multicenter, double-blind, placebo-controlled trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945131

28 May 2018

Effect of aprotinin on need for blood transfusion after repeat open-heart surgery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945131

28 May 2018

The risk-benefit profile of aprotinin versus tranexamic acid in cardiac surgery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945131

16 August 2018

The risks of aprotinin and tranexamic acid in cardiac surgery: a one-year follow-up of 1188 consecutive patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945131

16 August 2018

Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945131

16 August 2018

Meta-analysis comparing the effectiveness and adverse outcomes of antifibrinolytic agents in cardiac surgery.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945131

16 August 2018

A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945131

16 August 2018

The independent association of massive blood loss with mortality in cardiac surgery.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945131

16 August 2018

About dosage schemes and safety of tranexamic acid in cardiac surgery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945131

16 August 2018

Stroke after cardiac surgery: a risk factor analysis of 16,184 consecutive adult patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945131

16 August 2018

Convulsions and refractory ventricular fibrillation after intrathecal injection of a massive dose of tranexamic acid.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945131

16 August 2018

Epileptic seizures following cortical application of fibrin sealants containing tranexamic acid in rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945131

16 August 2018

Renal dysfunction and intravascular coagulation with aprotinin and hypothermic circulatory arrest

1 reference

https://pubmed.ncbi.nlm.nih.gov/20682059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intermittent antegrade warm blood cardioplegia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20682059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aprotinin in aortocoronary bypass surgery: increased risk of vein-graft occlusion and myocardial infarction? Supportive evidence from a retrospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20682059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

1 reference

Europe PubMed Central

PMC publication ID

30 October 2017

Dimensions Publication ID

0 references

release_jpqh43e4y5ha5nm6jk5verc2dm

1 reference

https://api.fatcat.wiki/v0/release/jpqh43e4y5ha5nm6jk5verc2dm

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

30 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

30 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42420172&oldid=1944432895"